Indaptus Therapeutics (INDP) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.63, -7.72% vs the prior close of $2.85.
- Volume 496.18K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
INDP slides 7.7% to $2.63. Closed at $2.63, -7.72% vs the prior close of $2.85. Day range $2.55–$2.87, opened at $2.85.
INDP daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — INDP slides 7.7% to $2.63
- Closed at $2.63, -7.72% vs the prior close of $2.85. Day range $2.55–$2.87, opened at $2.85.
- Volume was 496.18K shares, 0.5x its 50-day average of 1.09M — lighter than usual.
- Price is +23.0% vs its 50-day average ($2.14) and +15.5% vs its 200-day average ($2.28).
- 52-week range $0.92–$5.96; today's close sits at 34% of that range, 55.9% below the 52-week high.
Oct 15, 2026 — INDP jumps 29.0% to $2.85
- Closed at $2.85, +28.96% vs the prior close of $2.21. Day range $2.25–$2.89, opened at $2.25.
- Volume was 1.32M shares, 1.2x its 50-day average of 1.07M.
- Price is +35.0% vs its 50-day average ($2.11) and +25.1% vs its 200-day average ($2.28).
- 52-week range $0.92–$5.96; today's close sits at 38% of that range, 52.2% below the 52-week high.
Oct 14, 2026 — INDP slides 7.5% to $2.21, 3 down days in a row
- Closed at $2.21, -7.53% vs the prior close of $2.39. Day range $2.03–$2.40, opened at $2.34.
- Volume was 449.80K shares, 0.4x its 50-day average of 1.06M — lighter than usual.
- Price is +6.2% vs its 50-day average ($2.08) and -2.9% vs its 200-day average ($2.28).
- 52-week range $0.92–$5.96; today's close sits at 26% of that range, 62.9% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — INDP dips 2.0% to $2.39
- Closed at $2.39, -2.05% vs the prior close of $2.44. Day range $2.35–$2.52, opened at $2.44.
- Volume was 120.00K shares, 0.1x its 50-day average of 1.06M — lighter than usual.
- Price is +15.8% vs its 50-day average ($2.06) and +4.9% vs its 200-day average ($2.28).
- 52-week range $0.92–$5.96; today's close sits at 29% of that range, 59.9% below the 52-week high.
Oct 12, 2026 — INDP dips 2.8% to $2.44
- Closed at $2.44, -2.79% vs the prior close of $2.51. Day range $2.40–$2.71, opened at $2.50.
- Volume was 363.30K shares, 0.3x its 50-day average of 1.06M — lighter than usual.
- Price is +19.5% vs its 50-day average ($2.04) and +7.0% vs its 200-day average ($2.28).
- 52-week range $0.92–$5.96; today's close sits at 30% of that range, 59.1% below the 52-week high.
Oct 9, 2026 — INDP jumps 5.9% to $2.51
- Closed at $2.51, +5.91% vs the prior close of $2.37. Day range $2.35–$2.63, opened at $2.35.
- Volume was 467.60K shares, 0.4x its 50-day average of 1.05M — lighter than usual.
- Price is +24.3% vs its 50-day average ($2.02) and +10.2% vs its 200-day average ($2.28).
- 52-week range $0.92–$5.96; today's close sits at 32% of that range, 57.9% below the 52-week high.
Oct 8, 2026 — INDP jumps 4.9% to $2.37
- Closed at $2.37, +4.87% vs the prior close of $2.26. Day range $2.29–$2.53, opened at $2.37.
- Volume was 506.90K shares, 0.5x its 50-day average of 1.04M — lighter than usual.
- Price is +18.7% vs its 50-day average ($2.00) and +4.2% vs its 200-day average ($2.28).
- 52-week range $0.92–$5.96; today's close sits at 29% of that range, 60.2% below the 52-week high.
Oct 7, 2026 — INDP slides 12.7% to $2.26
- Closed at $2.26, -12.74% vs the prior close of $2.59. Day range $2.22–$2.57, opened at $2.57.
- Volume was 589.20K shares, 0.6x its 50-day average of 1.03M — lighter than usual.
- Price is +13.8% vs its 50-day average ($1.99) and -0.6% vs its 200-day average ($2.27).
- 52-week range $0.92–$5.96; today's close sits at 27% of that range, 62.1% below the 52-week high.
Oct 6, 2026 — INDP jumps 3.2% to $2.59, 3 up days in a row
- Closed at $2.59, +3.19% vs the prior close of $2.51. Day range $2.39–$2.61, opened at $2.51.
- Volume was 279.20K shares, 0.3x its 50-day average of 1.03M — lighter than usual.
- Price is +31.1% vs its 50-day average ($1.98) and +14.0% vs its 200-day average ($2.27).
- 52-week range $0.92–$5.96; today's close sits at 33% of that range, 56.5% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — INDP jumps 5.5% to $2.51
- Closed at $2.51, +5.46% vs the prior close of $2.38. Day range $2.25–$2.53, opened at $2.35.
- Volume was 361.50K shares, 0.4x its 50-day average of 1.03M — lighter than usual.
- Price is +27.8% vs its 50-day average ($1.96) and +10.5% vs its 200-day average ($2.27).
- 52-week range $0.92–$5.96; today's close sits at 32% of that range, 57.9% below the 52-week high.
Oct 2, 2026 — INDP jumps 12.3% to $2.38
- Closed at $2.38, +12.26% vs the prior close of $2.12. Day range $1.94–$2.42, opened at $2.11.
- Volume was 568.10K shares, 0.6x its 50-day average of 1.02M — lighter than usual.
- Price is +21.0% vs its 50-day average ($1.97) and +4.9% vs its 200-day average ($2.27).
- 52-week range $0.92–$5.96; today's close sits at 29% of that range, 60.1% below the 52-week high.
INDP latest news & SEC filings
Every SEC filing by or about INDP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Sep 8, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 1.01 — Signed a material agreement.
Sep 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 4, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 31, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 26, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 25, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 17, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.79M (prior year -$5.23M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.02 (prior year -$9.09) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 5.07 — Reported shareholder vote results.
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 17, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jul 16, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Things to know before you trade INDP
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 15, 2026, Nov 12, 2025, Aug 13, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 10.30% (largest 29.1%). That is a volatile stock.
- Liquidity: about 575.93K shares (≈$1.51M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.63 vs a range of $0.92–$5.96 (34% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:28 on Jun 27, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 30, 2026; 8-K Sep 10, 2026; 8-K Sep 4, 2026.
- Share count: 133.24M shares outstanding (Aug 13, 2026), +11941.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
INDP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.85 | 2.87 | 2.55 | 2.63 | 496.18K |
| Oct 15, 2026 | 2.25 | 2.89 | 2.25 | 2.85 | 1.32M |
| Oct 14, 2026 | 2.34 | 2.40 | 2.03 | 2.21 | 449.80K |
| Oct 13, 2026 | 2.44 | 2.52 | 2.35 | 2.39 | 120.00K |
| Oct 12, 2026 | 2.50 | 2.71 | 2.40 | 2.44 | 363.30K |
| Oct 9, 2026 | 2.35 | 2.63 | 2.35 | 2.51 | 467.60K |
| Oct 8, 2026 | 2.37 | 2.53 | 2.29 | 2.37 | 506.90K |
| Oct 7, 2026 | 2.57 | 2.57 | 2.22 | 2.26 | 589.20K |
| Oct 6, 2026 | 2.51 | 2.61 | 2.39 | 2.59 | 279.20K |
| Oct 5, 2026 | 2.35 | 2.53 | 2.25 | 2.51 | 361.50K |
| Oct 2, 2026 | 2.11 | 2.42 | 1.94 | 2.38 | 568.10K |
| Oct 1, 2026 | 2.28 | 2.41 | 2.08 | 2.12 | 478.50K |
| Sep 30, 2026 | 2.87 | 2.91 | 2.26 | 2.30 | 643.00K |
| Sep 29, 2026 | 3.24 | 3.32 | 2.81 | 2.85 | 589.30K |
| Sep 28, 2026 | 3.78 | 3.83 | 3.12 | 3.29 | 584.20K |
| Sep 25, 2026 | 3.99 | 3.99 | 3.46 | 3.85 | 570.90K |
| Sep 24, 2026 | 3.77 | 4.11 | 3.76 | 4.00 | 513.30K |
| Sep 23, 2026 | 3.93 | 4.22 | 3.57 | 3.77 | 624.60K |
| Sep 22, 2026 | 3.10 | 4.06 | 2.95 | 3.99 | 1.27M |
| Sep 21, 2026 | 3.55 | 3.55 | 2.90 | 3.09 | 718.80K |
About Indaptus Therapeutics
Indaptus Therapeutics (INDP) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1857044.
INDP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Avraham Ben-Tzvi | Director | Jan 22, 2026 |
| Jerome D Jabbour | Director | Feb 27, 2026 |
| David E. Lazar | Director | Mar 24, 2026 |
| Qinglai Lu | Director | Apr 20, 2026 |
| Matthew Charles Mcmurdo | Director | Feb 26, 2026 |
| Jeffrey A Meckler | Co-Chief Executive Officer | Feb 13, 2026 |
| David Natan | Director | Jan 22, 2026 |
| Michael James Newman | CSO and Director | Dec 29, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Junyi Dai | Chief Executive Officer | Apr 2, 2026 |
| Walt Addison Linscott | Chief Operating Officer | Dec 29, 2025 |
| Jeffrey A Meckler | Co-Chief Executive Officer | Feb 13, 2026 |
| Michael James Newman | CSO and Director | Dec 29, 2025 |
| Nir Sassi | Chief Financial Officer | Dec 29, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
INDP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-20.85M | -21.58 | $-14.82M |
| Dec 31, 2024 | — | $-15.02M | -44.96 | $-12.32M |
| Dec 31, 2023 | — | $-15.42M | -1.83 | $-13.41M |
| Dec 31, 2022 | — | $-14.32M | -1.73 | $-13.08M |
| Dec 31, 2021 | — | $-7.71M | — | $-11.29M |
Latest balance sheet: total assets $11.99M, total liabilities $615.43K, cash $7.55M (as of Jun 30, 2026).
INDP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $1.06 |
| May 15, 2026 | 8-K Item 2.02 (results) | $1.59 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $2.89 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $8.44 |
| May 14, 2025 | 8-K Item 2.02 (results) | $11.87 |
| Mar 13, 2025 | 8-K Item 2.02 (results) | $22.60 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $32.20 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Mar 13, 2024 | 8-K Item 2.02 (results) | — |
| Nov 6, 2023 | 8-K Item 2.02 (results) | — |
| Aug 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on INDP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.